Pregnancy Success Rates of Acupuncture for in Vitro Fertilization

Clinical Effectiveness of Acupuncture to Increase Pregnancy Success Rates for Women Undergoing in Vitro Fertilization: A Randomized Controlled Trial

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03572608

Acronym

Acupuncture

Enrollment

120

Registered

2018-06-28

Start date

2018-06-01

Completion date

2018-10-01

Last updated

2018-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility, Female

Keywords

acupuncture, infertility, pregnancy

Brief summary

This study evaluates the effectiveness of acupuncture on pregnancy success before embryo transfer in IVF treatment in female infertile patients. Half of participants will receive acupuncture sessions before embryo transfer, while the other half will not receive.

Detailed description

Acupuncture is used for many health problem all around the World. WHO reported that acupuncture can have benefit in female infertility treatment. However, there is no enough evidence about effectiveness of acupuncture treatment in the infertility.

Interventions

OTHERAcupuncture treatment

Classical acupuncture points will be used without a formal traditional Chinese medicine diagnosis in the intervention group. Neither manual needle stimulation nor moxibustion will used. The needles will left in place for 30 min and de qi was not sought. The points will be selected bilateral Heart-7, bilateral Large Intestine-4, Governing Vessel-20 and ear shenmen for the first session. Bilateral Conception Vessel-3,4,6, bilateral Liver-3, bilateral Stomach-30, bilateral Spleen-6, bilateral Governing Vessel-20 will be used for the second session. Bilateral Large Intestine-4, bilateral Spleen-6,9, bilateral Stomach-36 will be used for the last session. All acupuncture points will be selected and localized on the basis of the WHO Standardised Acupuncture Point Location.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

23 Years to 45 Years

Healthy volunteers

Inclusion criteria

* To have unexplained infertility * To go in vitro fertilization treatment * To give permission by informed consent form

Exclusion criteria

* Below age of 18 and above age of 45 * To have secondary infertility * To reject completing informed consent form

Design outcomes

Primary

Measure	Time frame	Description
pregnancy	2 weeks after the treatment	positive betaHCG

Secondary

Measure	Time frame	Description
Anxiety level	Through study completion, 2 weeks after the protocol	STAI-1 Inventory

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026